Your account is not claimed yet. You can sign up with ORCID to claim your account.

Romain Pelletier

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Pharmaceutics

Archives of toxicology

Journal of fungi (Basel, Switzerland)

CHU Rennes

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHU Rennes Nov 5o 2019 - Nov 5o 2023

France

Interne en Biologie Médicale :: Ille et Vilaine

Publications

Romain Pelletier, Brendan Le Daré, Diane Le Bouëdec, Alexis Bourdais, Pierre-Jean Ferron, Isabelle Morel, François-Hugues Porée, Thomas Gicquel
Identification, synthesis and quantification of eutylone consumption markers in a chemsex context. Archives of toxicology (2023)
Romain Pelletier, Alexis Bourdais, Nicolas Fabresse, Pierre-Jean Ferron, Isabelle Morel, Thomas Gicquel, Brendan Le Daré
In silico and in vitro metabolism studies of the new synthetic opiate AP-237 (bucinnazine) using bioinformatics tools. Archives of toxicology (2023)
Romain Pelletier, Thomas Gicquel, Mélanie Simoes Eugenio, Pierre-Jean Ferron, Isabelle Morel, Claire Delehouzé, Marie-Thérèse Dimanche-Boitrel, Morgane Rousselot, Brendan Le Daré
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics 14 (12) (2022)
Romain Pelletier, Brendan Le Daré, Diane Le Bouëdec, Angéline Kernalléguen, Pierre-Jean Ferron, Isabelle Morel, Thomas Gicquel
Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects. International journal of molecular sciences 23 (24) (2022)
Romain Pelletier, Thomas Gicquel, Mélanie Simoes Eugenio, Pierre-Jean Ferron, Isabelle Morel, Claire Delehouzé, Marie-Thérèse Dimanche-Boitrel, Morgane Rousselot, Brendan Le Daré
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics 14 (12) (2022)
Romain Pelletier, Brendan Le Daré, Diane Le Bouëdec, Angéline Kernalléguen, Pierre-Jean Ferron, Isabelle Morel, Thomas Gicquel
Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects. International journal of molecular sciences 23 (24) (2022)
Romain Pelletier, Thomas Gicquel, Mélanie Simoes Eugenio, Pierre-Jean Ferron, Isabelle Morel, Claire Delehouzé, Marie-Thérèse Dimanche-Boitrel, Morgane Rousselot, Brendan Le Daré
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics 14 (12) (2022)
Romain Pelletier, Thomas Gicquel, Mélanie Simoes Eugenio, Pierre-Jean Ferron, Isabelle Morel, Claire Delehouzé, Marie-Thérèse Dimanche-Boitrel, Morgane Rousselot, Brendan Le Daré
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline. Pharmaceutics 14 (12) (2022)
Romain Pelletier, Brendan Le Daré, Diane Le Bouëdec, Angéline Kernalléguen, Pierre-Jean Ferron, Isabelle Morel, Thomas Gicquel
Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects. International journal of molecular sciences 23 (24) (2022)
Romain Pelletier, Brendan Le Daré, Pierre-Jean Ferron, Diane Le Bouëdec, Angéline Kernalléguen, Isabelle Morel, Thomas Gicquel
Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP). Archives of toxicology (2022)
Romain Pelletier, Brendan Le Daré, Loic Grandin, Aurélien Couette, Pierre-Jean Ferron, Isabelle Morel, Thomas Gicquel
New psychoactive substance cocktail in an intensive care intoxication case elucidated by molecular networking. Clinical toxicology (Philadelphia, Pa.) (2021)
Pierre-Jean Ferron, Brendan Le Daré, Julie Bronsard, Clara Steichen, Elodie Babina, Romain Pelletier, Thierry Hauet, Isabelle Morel, Karin Tarte, Florian Reizine, Bruno Clément, Bernard Fromenty, Thomas Gicquel
Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients. International journal of molecular sciences 23 (1) (2021)
Thomas Gicquel, Romain Pelletier, Camille Richeval, Alexandr Gish, Florian Hakim, Pierre-Jean Ferron, Vadim Mesli, Delphine Allorge, Isabelle Morel, Jean-Michel Gaulier
Metabolite elucidation of 2-fluoro-deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo models. Drug testing and analysis (2021)
Jean-Pierre Gangneux, Florian Reizine, Hélène Guegan, Kieran Pinceaux, Pierre Le Balch, Emilie Prat, Romain Pelletier, Sorya Belaz, Mathieu Le Souhaitier, Yves Le Tulzo, Philippe Seguin, Mathieu Lederlin, Jean-Marc Tadié, Florence Robert-Gangneux
Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience. Journal of fungi (Basel, Switzerland) 6 (3) (2020)

Romain Pelletier.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Romain Pelletier